Item Type | Name |
Concept
|
B-Lymphocytes
|
Concept
|
Cells, Cultured
|
Concept
|
Dendritic Cells
|
Concept
|
Epithelial Cells
|
Concept
|
HeLa Cells
|
Concept
|
Killer Cells, Natural
|
Concept
|
Plasma Cells
|
Concept
|
T-Lymphocytes
|
Concept
|
T-Lymphocytes, Cytotoxic
|
Concept
|
Tumor Cells, Cultured
|
Concept
|
Vero Cells
|
Concept
|
CD4-Positive T-Lymphocytes
|
Concept
|
T-Lymphocyte Subsets
|
Concept
|
Lymphocytes, Tumor-Infiltrating
|
Concept
|
Lymphoma, T-Cell, Peripheral
|
Concept
|
CHO Cells
|
Concept
|
PC12 Cells
|
Concept
|
Jurkat Cells
|
Concept
|
COS Cells
|
Concept
|
K562 Cells
|
Concept
|
U937 Cells
|
Concept
|
HCT116 Cells
|
Concept
|
Natural Killer T-Cells
|
Concept
|
HEK293 Cells
|
Academic Article
|
Integrin receptors on tumor cells facilitate NK cell-mediated antibody-dependent cytotoxicity.
|
Academic Article
|
Enhanced NK-cell development and function in BCAP-deficient mice.
|
Grant
|
Understanding Psychosocial and Immunologic Responses in Indolent Lymphoproliferative Disorders
|
Grant
|
Characterization of Type-2 Cytokine-Producing NK Cells
|
Grant
|
Molecular Regulation of Inhibitory Killer Cell Ig-like Receptors
|
Grant
|
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
|
Grant
|
Role of immune receptor clustering in controlling efficacy of antibody-dependent Fc?RIIIa-mediated cytotoxicity by NK cells
|
Grant
|
Mechanisms of NK Cell Activation by the KIR2DL4 Receptor
|
Academic Article
|
SHP-1- and phosphotyrosine-independent inhibitory signaling by a killer cell Ig-like receptor cytoplasmic domain in human NK cells.
|
Academic Article
|
NKp44 triggers NK cell activation through DAP12 association that is not influenced by a putative cytoplasmic inhibitory sequence.
|
Academic Article
|
Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2) can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells.
|
Academic Article
|
Blocking NK cell inhibitory self-recognition promotes antibody-dependent cellular cytotoxicity in a model of anti-lymphoma therapy.
|
Academic Article
|
KIR2DL4 is an IL-2-regulated NK cell receptor that exhibits limited expression in humans but triggers strong IFN-gamma production.
|
Academic Article
|
Parallel purification of three catalytic subunits of the protein serine/threonine phosphatase 2A family (PP2A(C), PP4(C), and PP6(C)) and analysis of the interaction of PP2A(C) with alpha4 protein.
|
Academic Article
|
Receptors and lytic mediators regulating anti-tumor activity by the leukemic killer T cell line TALL-104.
|
Academic Article
|
KIR2DL5 can inhibit human NK cell activation via recruitment of Src homology region 2-containing protein tyrosine phosphatase-2 (SHP-2).
|
Academic Article
|
Altered gene expression in phenotypically normal renal cells from carriers of tumor suppressor gene mutations.
|
Academic Article
|
Protein kinase C regulates expression and function of inhibitory killer cell Ig-like receptors in NK cells.
|
Academic Article
|
NKp44 receptor mediates interaction of the envelope glycoproteins from the West Nile and dengue viruses with NK cells.
|
Academic Article
|
Altered gene expression in morphologically normal epithelial cells from heterozygous carriers of BRCA1 or BRCA2 mutations.
|
Academic Article
|
Proliferating cell nuclear antigen is a novel inhibitory ligand for the natural cytotoxicity receptor NKp44.
|
Academic Article
|
Haploinsufficiency in tumor predisposition syndromes: altered genomic transcription in morphologically normal cells heterozygous for VHL or TSC mutation.
|
Academic Article
|
An NK cell line (haNK) expressing high levels of granzyme and engineered to express the high affinity CD16 allele.
|
Academic Article
|
A Conserved HIV-1-Derived Peptide Presented by HLA-E Renders Infected T-cells Highly Susceptible to Attack by NKG2A/CD94-Bearing Natural Killer Cells.
|
Academic Article
|
Cutting edge: KIR2DL4 transduces signals into human NK cells through association with the Fc receptor gamma protein.
|
Academic Article
|
In vitro Evidence That Combination Therapy With CD16-Bearing NK-92 Cells and FDA-Approved Alefacept Can Selectively Target the Latent HIV Reservoir in CD4+ CD2hi Memory T Cells.
|
Academic Article
|
[Natural killer cells and cancer. Regulation by the killer cell Ig-like receptors (KIR)].
|
Academic Article
|
Suppressing the killer instinct.
|
Academic Article
|
Central nervous system acute lymphoblastic leukemia: role of natural killer cells.
|
Academic Article
|
Phase II Study of the PD-1 Inhibitor Pembrolizumab for the Treatment of Relapsed or Refractory Mature T-cell Lymphoma.
|
Academic Article
|
The ap-2 clathrin adaptor mediates endocytosis of an inhibitory killer cell Ig-like receptor in human NK cells.
|
Academic Article
|
Mechanisms of NK Cell Activation and Clinical Activity of the Therapeutic SLAMF7 Antibody, Elotuzumab in Multiple Myeloma.
|
Academic Article
|
PD-1 expression on peripheral blood cells increases with stage in renal cell carcinoma patients and is rapidly reduced after surgical tumor resection.
|
Academic Article
|
Dose intensification of TRAIL-inducing ONC201 inhibits metastasis and promotes intratumoral NK cell recruitment.
|
Academic Article
|
Tumor-Infiltrating Myeloid Cells Co-Express TREM1 and TREM2 and Elevated TREM-1 Associates With Disease Progression in Renal Cell Carcinoma.
|
Academic Article
|
Measuring intracellular calcium signaling in murine NK cells by flow cytometry.
|
Academic Article
|
Blocking the PCNA/NKp44 Checkpoint to Stimulate NK Cell Responses to Multiple Myeloma.
|
Academic Article
|
Inhibition of the NKp44-PCNA Immune Checkpoint Using a mAb to PCNA.
|
Academic Article
|
The Ca2+ sensor S100A1 modulates neuroinflammation, histopathology and Akt activity in the PSAPP Alzheimer's disease mouse model.
|
Academic Article
|
Regulation of natural cytotoxicity receptors by heparan sulfate proteoglycans in -cis: A lesson from NKp44.
|
Academic Article
|
Immunotherapy of cancer.
|
Academic Article
|
Characterization of the recognition of tumor cells by the natural cytotoxicity receptor, NKp44.
|
Academic Article
|
Expression of cDNAs in human Natural Killer cell lines by retroviral transduction.
|
Academic Article
|
NKp44 and NKp30 splice variant profiles in decidua and tumor tissues: a comparative viewpoint.
|
Academic Article
|
Natural Killer cell activation, reduced ACE2, TMPRSS2, cytokines G-CSF, M-CSF and SARS-CoV-2-S pseudovirus infectivity by MEK inhibitor treatment of human cells.
|
Academic Article
|
Prohibitins and the cytoplasmic domain of CD86 cooperate to mediate CD86 signaling in B lymphocytes.
|
Academic Article
|
B-cell adaptor for PI3K (BCAP) negatively regulates Toll-like receptor signaling through activation of PI3K.
|
Academic Article
|
Survival in acute myeloid leukemia is associated with NKp44 splice variants.
|
Academic Article
|
Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR).
|
Academic Article
|
Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma.
|
Academic Article
|
Harnessing natural killer cells for cancer immunotherapy: dispatching the first responders.
|
Academic Article
|
IL27 Signaling Serves as an Immunologic Checkpoint for Innate Cytotoxic Cells to Promote Hepatocellular Carcinoma.
|
Academic Article
|
Mystery Checkpoint Revealed: KIR3DL3 Finally Found a Ligand in HHLA2.
|
Academic Article
|
KIR2DL4 differentially signals downstream functions in human NK cells through distinct structural modules.
|
Academic Article
|
Prostaglandin D2 suppresses human NK cell function via signaling through D prostanoid receptor.
|
Academic Article
|
SHP-2 expression negatively regulates NK cell function.
|
Academic Article
|
Human immunodeficiency-causing mutation defines CD16 in spontaneous NK cell cytotoxicity.
|
Academic Article
|
TRAIL receptor agonists convert the response of breast cancer cells to ONC201 from anti-proliferative to apoptotic.
|
Academic Article
|
Correction: Cutting Edge: Role of NK Cells and Surfactant Protein D in Dendritic Cell Lymph Node Homing: Effects of Ozone Exposure.
|
Academic Article
|
Combination immune therapies to enhance anti-tumor responses by NK cells.
|
Academic Article
|
Genome-wide siRNA screen reveals a new cellular partner of NK cell receptor KIR2DL4: heparan sulfate directly modulates KIR2DL4-mediated responses.
|
Academic Article
|
mTOR-Dependent and Independent Survival Signaling by PI3K in B Lymphocytes.
|
Academic Article
|
The efficacy of combination treatment with elotuzumab and lenalidomide is dependent on crosstalk between natural killer cells, monocytes and myeloma cells.
|
Academic Article
|
Impacts of pembrolizumab therapy on immune phenotype in patients with high-grade neuroendocrine neoplasms.
|
Academic Article
|
NK cell dysfunction in chronic lymphocytic leukemia is associated with loss of the mature cells expressing inhibitory killer cell Ig-like receptors.
|
Academic Article
|
Conformational Changes in the Cytoplasmic Region of KIR3DL1 upon Interaction with SHP-2.
|
Academic Article
|
Introduction of shRNAs into human NK-like cell lines with retrovirus.
|
Academic Article
|
Ubiquitylation of an internalized killer cell Ig-like receptor by Triad3A disrupts sustained NF-?B signaling.
|
Academic Article
|
A novel mechanism for cancer cells to evade immune attack by NK cells: The interaction between NKp44 and proliferating cell nuclear antigen.
|
Academic Article
|
Cutting Edge: Role of NK Cells and Surfactant Protein D in Dendritic Cell Lymph Node Homing: Effects of Ozone Exposure.
|
Academic Article
|
Murine Cytomegalovirus Encodes a Specific Cell Surface Marker That Can Trigger Attack by NK Cells.
|
Academic Article
|
Derivation of human primary prostate epithelial cell lines by differentially targeting the CDKN2A locus along with expression of hTERT.
|